RxDoctor Payments Data

Kristi Culp

Physician Assistant · Orefield, PANPI 1427693845

Payments from drug & device makers

$2,971in general payments, 2019–2025

Across 148 payments — averaging $20.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$495
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$389
  • Alkermes, Inc.$300
  • Teva Pharmaceuticals USA, Inc.$292
  • Otsuka America Pharmaceutical, Inc.$250
  • Axsome Therapeutics, Inc.$239
  • plus $1K from 10 others

What the payments were for

  • Food & beverage$2,81095%
  • Education$1605%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,971 in reported general payments places this provider in the 85th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$9,616
Medicare patients
45
Services billed
136

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Austedo XrDeutetrabenazine15$115,547
Quetiapine Fumarate116$1,279
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine13$1,020
Fluoxetine Hcl73$844
Bupropion XlBupropion Hcl57$759
Aripiprazole42$694
Venlafaxine Hcl ErVenlafaxine Hcl56$632
Hydroxyzine Hcl28$623
Mirtazapine77$565
Olanzapine21$488
Divalproex Sodium25$376
Desvenlafaxine Succinate ErDesvenlafaxine Succinate18$360
Fluvoxamine Maleate11$353
Imipramine Hcl15$332
Trazodone Hcl65$322

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo Xr$292$115,54715 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Orefield

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →